https://www.gsk.com/en-gb/media/press-releases/statement-zantac-ranitidine-us-litigation/
Regulatory Opposition Mounts Over Activision For Microsoft Deal, UK’s Regulatory Watchdog Objects
Months after the U.K.’s Competition and Markets Authority (CMA) launched an antitrust investigation into Microsoft Corp’s (NASDAQ:MSFT) $68.7 billion Activision Blizzard…